Authors


Aneh Chumbow, PharmD Candidate

Latest:

Health Technology and the Rise of the E-Patient

Technology has become an essential part of health care.


Zachary Yuschock, PharmD Candidate

Latest:

Boehringer Ingelheim Pharmaceuticals' Pradaxa

Pradaxa (dabigatran etexilate) is the first oral direct thrombin inhibitor to be approved by the FDA.


Emily Woulfe, PharmD Candidate

Latest:

New Antimicrobials Expand Treatment Options

Eravacycline, Omadacycline, Plazomicin, and a Rifamycin Add to the Armamentarium for Treating Resistant Infections


Chigo Oguh, PharmD Candidate

Latest:

Taking Home Gold and the DC Public Health Case Challenge

Each year, the National Academy of Medicine hosts its DC Public Health Case Challenge to promote interdisciplinary, problem-based learning that focuses on an important public health issue facing the Washington, DC community



Ron Lanton, Esq

Latest:

Three Current Policy Discussions Influencing Cancer Drug Development

Despite progress in reducing cancer mortality, more work is needed to improve patient outcomes in this disease state.




Mary-Haston Vest, PharmD, MS

Latest:

Securing Specialty Oncology Contracts in a Data-Driven World

Data aggregation partners can provide value in their ability to pull clinical information from both the HSSP and electronic health records.



Jennifer Gershman, PharmD, CPh, PACS

Latest:

Pharmacists Can Directly Improve Health Literacy

Incorporating the teach-back method and providing patient handouts expand health knowledge.



Bethany Spadaro, RPh, CDE, BCGP

Latest:

Hereditary Angioedema: The Pharmacist's Role in Team-Based Patient Care

As medication experts, pharmacists are integral to team-based care, providing the requisite knowledge for medication therapy management, as well as initiating, modifying and monitoring drug therapy to benefit patient care.


Michelle Putney, PharmD Candidate

Latest:

Ubrelvy: Treatment for Acute Migraines With or Without Aura in Adults

Ubrogepant (Ubrelvy, Allergan) was approved for the treatment of acute migraines with or without aura in adults after showing a significantly greater reduction in headache pain compared with placebo.


Kelly Fust, MS

Latest:

Economic Model of Granulocyte Colony-Stimulating Factors for Patients Receiving Chemotherapy

For US payers, pegfilgrastim is a less-expensive choice than daily filgrastim for reducing the risk of febrile neutropenia in patients receiving myelosuppressive chemotherapy.


Sharlene Ghassemi, PharmD

Latest:

Why I Became a Pharmacist: Searching for Cures, Making a Difference

The winner of our third annual essay contest shares her story.


Kathleen Kenny, PharmD, RPh

Latest:

Communication Skills Are Crucial for Patient Safety

Effectively educating patients about their medications and disease trajectory can improve adherence and outcomes.


Molly Burich, MS

Latest:

Manufacturer Considerations for Designing a Distribution Strategy for Specialty Products

The rising cost of specialty drugs continues to put pressure on all stakeholders. Specialty pharmacists can fill an existing gap in compliance and cost control.


Xianglin L. Du, MD, PhD

Latest:

Cost-Utility Analysis of Treatments for Advanced Non-Small Cell Lung Cancer

A national community-level study of Medicare patients with advanced non-small cell lung cancer found that adding targeted therapy to chemotherapy regimens was not cost-effective.


Nikhil A. Sangave, PharmD, BCACP

Latest:

Artificial Intelligence Applications in Education and Pharmacy Practice

By interpreting and applying the data provided by algorithms, pharmacists are uniquely equipped to guide development of more patient-centered care.


Marcus Sredzinski, PharmD

Latest:

Implications of STeP for Improved Diabetes Control: A Payer Perspective

Implementation of the STeP program across managed care organizations could lead to improved patient outcomes and significant cost savings.


Samuel W. Chey

Latest:

US Primary Care Providers' Use of Over-the-Counter Medications for Gastroesophageal Reflux Disease and Chronic Constipation

The perception and utilization of OTC medications among primary care providers for gastroesophageal reflux disease and chronic constipation shows a need for improved patient education on these medications.


Brittany Hoffmann-Eubanks, PharmD, MBA

Latest:

Student Pharmacist Leaders Discuss the Future of Pharmacy

Student pharmacist leaders were also asked about the importance of a pharmacist education in obtaining advanced pharmacist roles in their careers.


Jerica Singleton, PharmD

Latest:

Ensuring Access to Vaccinations Among Older Adults and Underserved Populations

A broader understanding of vaccine hesitancy and barriers has helped to enhance acceptance of vaccination services through educational outreach.


Maureen Miller, MPH, BSN

Latest:

Medicare Part D Plans Burdened by Hospice Payment Reform

Recent guidance and proposed rules for the Medicare hospice program will have a profound impact on plans providing Medicare Part D services.


Nicholas Feola, PharmD

Latest:

Treatment of Acute Venous Thromboembolism in Obese Patients

In the United States, as many as 900,000 individuals are affected by venous thromboembolism each year.


Julie Hessick, RPh

Latest:

Electronic Prior Authorization: The First Step in Patient Adherence

A streamlined prior authorization process can increase administrative efficiency and improve health information security.


Norman Nagl, PhD

Latest:

5-HT3 Receptor Antagonist Effects in Cancer Patients With Multiple Risk Factors

Palonosetron has been found to be effective in treating chemotherapy-induced nausea and vomiting, but no other studies that have compared it with the other 5-HT3 RAs are currently available.


Susie Lee, 2017 PharmD Candidate

Latest:

Success Stories of Interprofessional Education

Like many things at a large state school, in order to find opportunities, you must seek them yourself.